Objective To detect the values of NT-proBNP and evaluate its relationship with liver function,cardiac structure,and cardiac function which was evaluated by echocardiography in patients with liver cirrhosis.Methods A t...Objective To detect the values of NT-proBNP and evaluate its relationship with liver function,cardiac structure,and cardiac function which was evaluated by echocardiography in patients with liver cirrhosis.Methods A total of 50 liver cirrhotic patients and 11 healthy controls were studied by two dimensional Doppler echocardiography.Liver cirrhotic patients were divided into group A,B and C according to the Child-Pugh score.Cardiac dimensions and left and right ventricular functions were also evaluated.At the same time,the serum NTproBNP of liver cirrhotic patients and healthy controls were detected,respectively.Results By Comparison between two groups,we found that the values of LVd,LAs,LVPW,AAO,A Wave,RVOTs,PV and NT-proBNP in liver cirrhosis group were higher than those in control group,whereas the value of E/A decreased.As for the value of LAs and serum NT-proBNP,A and B group were all lower than C group.With LAs>35 mm,the number of cases in liver cirrhosis group was higher than that in control group.So did that With E/A<1.Conclusions The cardiac dysfunction confirmed the existence of cirrhotic cardiomyopathy.More clinical implications were found in liver cirrhotic patients with increased values of serum NT-proBNP.展开更多
Objective:To investigate the clinical significance of coagulation function, blood gas analysis and serum N-terminal pro-brain natriuretic peptide (NT-proBNP) level detection in patients with chronic obstructive pulmon...Objective:To investigate the clinical significance of coagulation function, blood gas analysis and serum N-terminal pro-brain natriuretic peptide (NT-proBNP) level detection in patients with chronic obstructive pulmonary disease (COPD).Methods: A total of 98 cases of COPD patients were selected and divided per different disease courses. For COPD acute exacerbation (AECOPD) stage, 53 patients were selected and set as group A. 45 cases of COPD patients in COPD stable stage were set as group B, and 50 cases of healthy people who received physical examination in our hospital in the corresponding period were collected and set as healthy controls (group C). Levels of PT, APTT, TT, Fbg, D-D, PaCO2, PaO2 and serum NT-proBNP in the whole 3 groups of patients were detected. Differences of index levels among the 3 groups and between before and after treatment in AECOPD patients were compared separately. The correlations of NT-proBNP, coagulation relevant indexes and arterial blood gas relevant indexes were analyzed.Results: (1) PT, APTT in group A and PT, APTT in group B were obviously longer than which in group C, and group A showed more significant variations. (2) Fbg, D-D, PaCO2, NT-proBNP in group A and Fbg, D-D, PaCO2, NT-proBNP in group B were obviously higher than which in group C;But PaO2 in group A and PaO2 in group B were significantly lower than which in group C;Group A showed more significant variations. (3) After treatment, PT and APTT in AECOPD patients were shorter than which before treatment, Fbg, D-D, PaCO2 and NT-proBNP were lower than before treatment, but PaO2 was higher than before treatment. (4) TT in group A were significantly longer than in group C, and differences showed no significance on comparison of TT between patients of group A and B, B and C and within A before and after treatment. (5) NT-proBNP in COPD patients showed significantly positive correlation separately with APTT, Fbg, D-D and PaCO2, showed significantly negative correlation with PaO2, but showed no obvious correlation with PT.Conclusion: Coagulation function and blood gas analysis combined with serum NT-proBNP level detection could better judge the severity of COPD. It shows significant reference value on clinical diagnosis, disease monitoring and evaluation for COPD patients.展开更多
INTRODUCTION B-type natriuretic peptide （BNP） is a 32- amino acid polypeptide secreted by ventricular myocytes during period of increased ventricu- lar stretch and wall tension. It is believed that the peptide play...INTRODUCTION B-type natriuretic peptide （BNP） is a 32- amino acid polypeptide secreted by ventricular myocytes during period of increased ventricu- lar stretch and wall tension. It is believed that the peptide plays an important role in the reg- ulation of blood pressure, blood volume, and sodium balance. Because in vitro studies have reported that natriuretic peptides are directly released from cardiomyocytes in response to myocardial ischemia , it has been proposed that their circulating levels are relevant to sub- sequent risk of cardiovascular diseases （CVDs） other than heart failure.展开更多
目的:检测慢性心力衰竭(CHF)患者血清Ⅲ型前胶原氨基末端前肽(N-terminal peptide of typeⅢprocollagen,PⅢNP)、高迁移率族蛋白B1(high mobility group box-1,HMGB1)的表达水平,探讨二者与左室射血分数(LVEF)的相关性以及对CHF的诊断...目的:检测慢性心力衰竭(CHF)患者血清Ⅲ型前胶原氨基末端前肽(N-terminal peptide of typeⅢprocollagen,PⅢNP)、高迁移率族蛋白B1(high mobility group box-1,HMGB1)的表达水平,探讨二者与左室射血分数(LVEF)的相关性以及对CHF的诊断价值。方法:收集2021年12月至2022年11月期间于佳木斯大学附属第一医院心内科住院治疗的慢性心力衰竭患者90例为实验组,按照LVEF将其分为HFrEF组(n=33)、HFmrEF组(n=27)和HFpEF组(n=30)。此外选取排除心功能不全诊断的同期住院患者30例为对照组。对比各组患者血清中氨基末端脑钠肽前体(NT-proBNP)、PⅢNP、HMGB1水平的差异,分析PⅢNP、HMGB1水平与心功能指标的相关性,并借助ROC曲线评估NT-proBNP、HMGB1、PⅢNP单独以及联合应用对不同表型CHF患者的诊断价值。结果:HFrEF组PⅢNP、HMGB1及NT-proBNP水平均高于HFpEF组和对照组,差异有统计学意义(P<0.05)。PⅢNP与HMGB1呈正相关(P<0.05);PⅢNP、HMGB1均与NT-proBNP、LVEDD呈正相关,与LVEF呈明显负相关(P<0.05);HMGB1与LAD呈正相关(P<0.05),PⅢNP与LAD无明显相关性(P>0.05)。血清NT-proBNP、HMGB1、PⅢNP水平诊断HFrEF患者的AUC分别为0.867、0.871、0.779;诊断HFmrEF患者的AUC分别为0.840、0.804、0.760;诊断HFpEF患者的AUC分别为0.851、0.728、0.769。多生物标志物模型NT-proBNP+PⅢNP、NT-proBNP+HMGB1、NT-proBNP+PⅢNP+HMGB1诊断HFrEF患者的AUC分别为0.887、0.954、0.954;诊断HFmrEF患者的AUC分别为0.942、0.937、0.951;诊断HFpEF患者的AUC分别为0.904、0.910、0.914。结论:CHF患者血清PⅢNP、HMGB1明显升高,并且,CHF患者血清PⅢNP、HMGB1水平与心脏功能指标具有良好的相关性,说明PⅢNP、HMGB1可反映疾病的严重程度。PⅢNP、HMGB1对各表型CHF患者均具有诊断价值,并且,多生物标志物联合检测能提高对CHF患者诊断的敏感性。展开更多
Objective:To study the correlation of serum MR-ProANP and NT-ProBNP content with pump function and ventricular remodeling in patients with left heart failure.Methods:A total of 104 patients with chronic heart failure ...Objective:To study the correlation of serum MR-ProANP and NT-ProBNP content with pump function and ventricular remodeling in patients with left heart failure.Methods:A total of 104 patients with chronic heart failure treated in our hospital between May 2013 and May 2016 were selected as the heart failure group of the research and 95 healthy volunteers receiving physical examination in our hospital over the same period were selected as the control group of the research. Serum was collected to detect the content of MR-ProANP, NT-ProBNP as well as ventricular remodeling-related molecules, and cardiac color Doppler ultrasonography was conducted to determine the heart pump function- and myocardial remodeling-related parameters.Results:Serum MR-ProANP, NT-ProBNP, MMP2, MMP9, MMP10, PICP and PIIINP content as well as ultrasound parameters IVSd, PWT, LVMI, MWS levels of heart failure group were significantly higher than those of control group, ultrasound parameters LAEF, LAPEF and LAAEF levels were significantly lower than those of control group;serum MR-ProANP and NT-ProBNP content were positively correlated with ultrasound parameters IVSd, PWT, LVMI, MWS as well as serum MMP2, MMP9, MMP10, PICP and PIIINP content, negatively correlated with ultrasound parameters LAEF, LAPEF and LAAEF, and the correlation coefficients of MR-ProANP with these indexes were all higher than those of NT-ProBNP.Conclusion:Serum MR-ProANP and NT-ProBNP content in patients with left heart failure are closely related to the pump function and ventricular remodeling, and MR-ProANP is more valuable for evaluating pump function decrease and ventricular remodeling increase.展开更多
Heart failure(HF)is a serious and advanced stage of heart disease that has remained a major public health threat despite advances in medical therapy.HF prevalence in developed countries is 1.5%–2.0%and significantly ...Heart failure(HF)is a serious and advanced stage of heart disease that has remained a major public health threat despite advances in medical therapy.HF prevalence in developed countries is 1.5%–2.0%and significantly increases with age,with a reported HF prevalence of≥10%in patients aged>70 years.展开更多
BACKGROUND Despite significant advancements in the medical treatment of primary hepato-cellular carcinoma(PHC)in recent years,enhancing therapeutic effects and im-proving prognosis remain substantial challenges worldw...BACKGROUND Despite significant advancements in the medical treatment of primary hepato-cellular carcinoma(PHC)in recent years,enhancing therapeutic effects and im-proving prognosis remain substantial challenges worldwide.AIM To investigate the expression levels of serum vascular endothelial growth factor(VEGF)and interleukin(IL)-17 in patients with PHC and evaluate their diagnostic value while exploring their relationship with patients’clinical characteristics.METHODS The study included 50 patients with confirmed PHC who visited Wuhan Han-yang Hospital from January 2021 to January 2022,and 50 healthy individuals from the same period served as the control group.Serum VEGF and IL-17 levels in both groups were measured by Enzyme-Linked Immunosorbent Assay,and their diagnostic value was assessed using receiver operating characteristic(ROC)curves.Pearson correlation analysis was performed to examine the relationship between serum VEGF and IL-17 levels.Pathological data of the PHC patients were analyzed to determine the relationship between serum VEGF and IL-17 levels and pathological characteristics.RESULTS Serum VEGF and IL-17 levels were significantly higher in the study group com-pared to the control group(P<0.05).No significant association was observed between serum VEGF and IL-17 levels and gender,age,combined cirrhosis,tumor diameter,or degree of differentiation(P>0.05).However,there was a significant relationship between clinical TNM stage,tumor metastasis,and serum VEGF and IL-17 levels(P<0.05).Correlation analysis revealed a positive correlation between serum VEGF and IL-17(P<0.05).ROC analysis demonstrated that both serum VEGF and IL-17 had good diagnostic efficacy for PHC.CONCLUSION Serum VEGF and IL-17 levels were significantly higher in PHC patients compared to healthy individuals.Their levels were closely related to pathological features such as tumor metastasis and clinical TNM stage,and there was a significant positive correlation between VEGF and IL-17.These biomarkers may serve as valuable reference in-dicators for the early diagnosis and treatment guidance of PHC.展开更多
BACKGROUND Coronary heart disease(CHD)and heart failure(HF)are the major causes of morbidity and mortality worldwide.Early and accurate diagnoses of CHD and HF are essential for optimal management and prognosis.Howeve...BACKGROUND Coronary heart disease(CHD)and heart failure(HF)are the major causes of morbidity and mortality worldwide.Early and accurate diagnoses of CHD and HF are essential for optimal management and prognosis.However,conventional diagnostic methods such as electrocardiography,echocardiography,and cardiac biomarkers have certain limitations,such as low sensitivity,specificity,availability,and cost-effectiveness.Therefore,there is a need for simple,noninvasive,and reliable biomarkers to diagnose CHD and HF.AIM To investigate serum cystatin C(Cys-C),monocyte/high-density lipoprotein cholesterol ratio(MHR),and uric acid(UA)diagnostic values for CHD and HF.METHODS We enrolled 80 patients with suspected CHD or HF who were admitted to our hospital between July 2022 and July 2023.The patients were divided into CHD(n=20),HF(n=20),CHD+HF(n=20),and control groups(n=20).The serum levels of Cys-C,MHR,and UA were measured using immunonephelometry and an enzymatic method,respectively,and the diagnostic values for CHD and HF were evaluated using receiver operating characteristic(ROC)curve analysis.RESULTS Serum levels of Cys-C,MHR,and UA were significantly higher in the CHD,HF,and CHD+HF groups than those in the control group.The serum levels of Cys-C,MHR,and UA were significantly higher in the CHD+HF group than those in the CHD or HF group.The ROC curve analysis showed that serum Cys-C,MHR,and UA had good diagnostic performance for CHD and HF,with areas under the curve ranging from 0.78 to 0.93.The optimal cutoff values of serum Cys-C,MHR,and UA for diagnosing CHD,HF,and CHD+HF were 1.2 mg/L,0.9×10^(9),and 389μmol/L;1.4 mg/L,1.0×10^(9),and 449μmol/L;and 1.6 mg/L,1.1×10^(9),and 508μmol/L,respectively.CONCLUSION Serum Cys-C,MHR,and UA are useful biomarkers for diagnosing CHD and HF,and CHD+HF.These can provide information for decision-making and risk stratification in patients with CHD and HF.展开更多
文摘Objective To detect the values of NT-proBNP and evaluate its relationship with liver function,cardiac structure,and cardiac function which was evaluated by echocardiography in patients with liver cirrhosis.Methods A total of 50 liver cirrhotic patients and 11 healthy controls were studied by two dimensional Doppler echocardiography.Liver cirrhotic patients were divided into group A,B and C according to the Child-Pugh score.Cardiac dimensions and left and right ventricular functions were also evaluated.At the same time,the serum NTproBNP of liver cirrhotic patients and healthy controls were detected,respectively.Results By Comparison between two groups,we found that the values of LVd,LAs,LVPW,AAO,A Wave,RVOTs,PV and NT-proBNP in liver cirrhosis group were higher than those in control group,whereas the value of E/A decreased.As for the value of LAs and serum NT-proBNP,A and B group were all lower than C group.With LAs>35 mm,the number of cases in liver cirrhosis group was higher than that in control group.So did that With E/A<1.Conclusions The cardiac dysfunction confirmed the existence of cirrhotic cardiomyopathy.More clinical implications were found in liver cirrhotic patients with increased values of serum NT-proBNP.
文摘Objective:To investigate the clinical significance of coagulation function, blood gas analysis and serum N-terminal pro-brain natriuretic peptide (NT-proBNP) level detection in patients with chronic obstructive pulmonary disease (COPD).Methods: A total of 98 cases of COPD patients were selected and divided per different disease courses. For COPD acute exacerbation (AECOPD) stage, 53 patients were selected and set as group A. 45 cases of COPD patients in COPD stable stage were set as group B, and 50 cases of healthy people who received physical examination in our hospital in the corresponding period were collected and set as healthy controls (group C). Levels of PT, APTT, TT, Fbg, D-D, PaCO2, PaO2 and serum NT-proBNP in the whole 3 groups of patients were detected. Differences of index levels among the 3 groups and between before and after treatment in AECOPD patients were compared separately. The correlations of NT-proBNP, coagulation relevant indexes and arterial blood gas relevant indexes were analyzed.Results: (1) PT, APTT in group A and PT, APTT in group B were obviously longer than which in group C, and group A showed more significant variations. (2) Fbg, D-D, PaCO2, NT-proBNP in group A and Fbg, D-D, PaCO2, NT-proBNP in group B were obviously higher than which in group C;But PaO2 in group A and PaO2 in group B were significantly lower than which in group C;Group A showed more significant variations. (3) After treatment, PT and APTT in AECOPD patients were shorter than which before treatment, Fbg, D-D, PaCO2 and NT-proBNP were lower than before treatment, but PaO2 was higher than before treatment. (4) TT in group A were significantly longer than in group C, and differences showed no significance on comparison of TT between patients of group A and B, B and C and within A before and after treatment. (5) NT-proBNP in COPD patients showed significantly positive correlation separately with APTT, Fbg, D-D and PaCO2, showed significantly negative correlation with PaO2, but showed no obvious correlation with PT.Conclusion: Coagulation function and blood gas analysis combined with serum NT-proBNP level detection could better judge the severity of COPD. It shows significant reference value on clinical diagnosis, disease monitoring and evaluation for COPD patients.
文摘INTRODUCTION B-type natriuretic peptide （BNP） is a 32- amino acid polypeptide secreted by ventricular myocytes during period of increased ventricu- lar stretch and wall tension. It is believed that the peptide plays an important role in the reg- ulation of blood pressure, blood volume, and sodium balance. Because in vitro studies have reported that natriuretic peptides are directly released from cardiomyocytes in response to myocardial ischemia , it has been proposed that their circulating levels are relevant to sub- sequent risk of cardiovascular diseases （CVDs） other than heart failure.
文摘目的:检测慢性心力衰竭(CHF)患者血清Ⅲ型前胶原氨基末端前肽(N-terminal peptide of typeⅢprocollagen,PⅢNP)、高迁移率族蛋白B1(high mobility group box-1,HMGB1)的表达水平,探讨二者与左室射血分数(LVEF)的相关性以及对CHF的诊断价值。方法:收集2021年12月至2022年11月期间于佳木斯大学附属第一医院心内科住院治疗的慢性心力衰竭患者90例为实验组,按照LVEF将其分为HFrEF组(n=33)、HFmrEF组(n=27)和HFpEF组(n=30)。此外选取排除心功能不全诊断的同期住院患者30例为对照组。对比各组患者血清中氨基末端脑钠肽前体(NT-proBNP)、PⅢNP、HMGB1水平的差异,分析PⅢNP、HMGB1水平与心功能指标的相关性,并借助ROC曲线评估NT-proBNP、HMGB1、PⅢNP单独以及联合应用对不同表型CHF患者的诊断价值。结果:HFrEF组PⅢNP、HMGB1及NT-proBNP水平均高于HFpEF组和对照组,差异有统计学意义(P<0.05)。PⅢNP与HMGB1呈正相关(P<0.05);PⅢNP、HMGB1均与NT-proBNP、LVEDD呈正相关,与LVEF呈明显负相关(P<0.05);HMGB1与LAD呈正相关(P<0.05),PⅢNP与LAD无明显相关性(P>0.05)。血清NT-proBNP、HMGB1、PⅢNP水平诊断HFrEF患者的AUC分别为0.867、0.871、0.779;诊断HFmrEF患者的AUC分别为0.840、0.804、0.760;诊断HFpEF患者的AUC分别为0.851、0.728、0.769。多生物标志物模型NT-proBNP+PⅢNP、NT-proBNP+HMGB1、NT-proBNP+PⅢNP+HMGB1诊断HFrEF患者的AUC分别为0.887、0.954、0.954;诊断HFmrEF患者的AUC分别为0.942、0.937、0.951;诊断HFpEF患者的AUC分别为0.904、0.910、0.914。结论:CHF患者血清PⅢNP、HMGB1明显升高,并且,CHF患者血清PⅢNP、HMGB1水平与心脏功能指标具有良好的相关性,说明PⅢNP、HMGB1可反映疾病的严重程度。PⅢNP、HMGB1对各表型CHF患者均具有诊断价值,并且,多生物标志物联合检测能提高对CHF患者诊断的敏感性。
文摘Objective:To study the correlation of serum MR-ProANP and NT-ProBNP content with pump function and ventricular remodeling in patients with left heart failure.Methods:A total of 104 patients with chronic heart failure treated in our hospital between May 2013 and May 2016 were selected as the heart failure group of the research and 95 healthy volunteers receiving physical examination in our hospital over the same period were selected as the control group of the research. Serum was collected to detect the content of MR-ProANP, NT-ProBNP as well as ventricular remodeling-related molecules, and cardiac color Doppler ultrasonography was conducted to determine the heart pump function- and myocardial remodeling-related parameters.Results:Serum MR-ProANP, NT-ProBNP, MMP2, MMP9, MMP10, PICP and PIIINP content as well as ultrasound parameters IVSd, PWT, LVMI, MWS levels of heart failure group were significantly higher than those of control group, ultrasound parameters LAEF, LAPEF and LAAEF levels were significantly lower than those of control group;serum MR-ProANP and NT-ProBNP content were positively correlated with ultrasound parameters IVSd, PWT, LVMI, MWS as well as serum MMP2, MMP9, MMP10, PICP and PIIINP content, negatively correlated with ultrasound parameters LAEF, LAPEF and LAAEF, and the correlation coefficients of MR-ProANP with these indexes were all higher than those of NT-ProBNP.Conclusion:Serum MR-ProANP and NT-ProBNP content in patients with left heart failure are closely related to the pump function and ventricular remodeling, and MR-ProANP is more valuable for evaluating pump function decrease and ventricular remodeling increase.
基金supported by a grant from the Science and Technology program of Liaoning Province[No.2018225003]
文摘Heart failure(HF)is a serious and advanced stage of heart disease that has remained a major public health threat despite advances in medical therapy.HF prevalence in developed countries is 1.5%–2.0%and significantly increases with age,with a reported HF prevalence of≥10%in patients aged>70 years.
文摘BACKGROUND Despite significant advancements in the medical treatment of primary hepato-cellular carcinoma(PHC)in recent years,enhancing therapeutic effects and im-proving prognosis remain substantial challenges worldwide.AIM To investigate the expression levels of serum vascular endothelial growth factor(VEGF)and interleukin(IL)-17 in patients with PHC and evaluate their diagnostic value while exploring their relationship with patients’clinical characteristics.METHODS The study included 50 patients with confirmed PHC who visited Wuhan Han-yang Hospital from January 2021 to January 2022,and 50 healthy individuals from the same period served as the control group.Serum VEGF and IL-17 levels in both groups were measured by Enzyme-Linked Immunosorbent Assay,and their diagnostic value was assessed using receiver operating characteristic(ROC)curves.Pearson correlation analysis was performed to examine the relationship between serum VEGF and IL-17 levels.Pathological data of the PHC patients were analyzed to determine the relationship between serum VEGF and IL-17 levels and pathological characteristics.RESULTS Serum VEGF and IL-17 levels were significantly higher in the study group com-pared to the control group(P<0.05).No significant association was observed between serum VEGF and IL-17 levels and gender,age,combined cirrhosis,tumor diameter,or degree of differentiation(P>0.05).However,there was a significant relationship between clinical TNM stage,tumor metastasis,and serum VEGF and IL-17 levels(P<0.05).Correlation analysis revealed a positive correlation between serum VEGF and IL-17(P<0.05).ROC analysis demonstrated that both serum VEGF and IL-17 had good diagnostic efficacy for PHC.CONCLUSION Serum VEGF and IL-17 levels were significantly higher in PHC patients compared to healthy individuals.Their levels were closely related to pathological features such as tumor metastasis and clinical TNM stage,and there was a significant positive correlation between VEGF and IL-17.These biomarkers may serve as valuable reference in-dicators for the early diagnosis and treatment guidance of PHC.
文摘BACKGROUND Coronary heart disease(CHD)and heart failure(HF)are the major causes of morbidity and mortality worldwide.Early and accurate diagnoses of CHD and HF are essential for optimal management and prognosis.However,conventional diagnostic methods such as electrocardiography,echocardiography,and cardiac biomarkers have certain limitations,such as low sensitivity,specificity,availability,and cost-effectiveness.Therefore,there is a need for simple,noninvasive,and reliable biomarkers to diagnose CHD and HF.AIM To investigate serum cystatin C(Cys-C),monocyte/high-density lipoprotein cholesterol ratio(MHR),and uric acid(UA)diagnostic values for CHD and HF.METHODS We enrolled 80 patients with suspected CHD or HF who were admitted to our hospital between July 2022 and July 2023.The patients were divided into CHD(n=20),HF(n=20),CHD+HF(n=20),and control groups(n=20).The serum levels of Cys-C,MHR,and UA were measured using immunonephelometry and an enzymatic method,respectively,and the diagnostic values for CHD and HF were evaluated using receiver operating characteristic(ROC)curve analysis.RESULTS Serum levels of Cys-C,MHR,and UA were significantly higher in the CHD,HF,and CHD+HF groups than those in the control group.The serum levels of Cys-C,MHR,and UA were significantly higher in the CHD+HF group than those in the CHD or HF group.The ROC curve analysis showed that serum Cys-C,MHR,and UA had good diagnostic performance for CHD and HF,with areas under the curve ranging from 0.78 to 0.93.The optimal cutoff values of serum Cys-C,MHR,and UA for diagnosing CHD,HF,and CHD+HF were 1.2 mg/L,0.9×10^(9),and 389μmol/L;1.4 mg/L,1.0×10^(9),and 449μmol/L;and 1.6 mg/L,1.1×10^(9),and 508μmol/L,respectively.CONCLUSION Serum Cys-C,MHR,and UA are useful biomarkers for diagnosing CHD and HF,and CHD+HF.These can provide information for decision-making and risk stratification in patients with CHD and HF.
